Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Agency for Science, Technology, and Research

Latest From Tapestry Pharmaceuticals Inc.

Pipeline Watch: Phase III Starts With Filgotinib, Gilteritinib And Nivolumab

Pipeline Watch has been updated to bring greater depth and detail to a potential therapeutic product’s progress through the R&D pipeline. The table brings you a snapshot of selected late-stage clinical trial events in the pharma and biotech industries.

Pipeline Watch Clinical Trials

New appointment at Advanced Cancer Therapeutics

Dr Gilles Tapolsky has joined Advanced Cancer Therapeutics (US) as chief scientific officer. He has more than 20 years' experience in corporate management, research and pharmaceutical development, having previously served as vice-president of product development at Tapestry Pharmaceuticals.

Cancer Companies
See All